当前位置： SCI文献检索 > Brachytherapy期刊下所有文献 > Review of brachytherapy complications - Upper gastrointestinal tract.

Review of brachytherapy complications - Upper gastrointestinal tract.

Abstract：

:While brachytherapy applications are not widely used for cancer diagnoses in the upper GI tract (including the esophagus, liver, stomach, and pancreas), they have a clear role in palliation and symptom management and occasionally definitive locoregional treatment. With the increasing use of image-guided techniques, the incidence of side effects and complications has shown to be lower than many other alternative treatment modalities, making brachytherapy approaches a preferred treatment option. This review examines procedural complications and acute and chronic adverse effects from radiation associated with esophageal, hepatobiliary, and pancreatic brachytherapy and their management.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Folkert MR,Gottumukkala S,Nguyen NT,Taggar A,Sur RK

doi

10.1016/j.brachy.2020.11.010

subject

Has Abstract

pub_date

2020-12-22 00:00:00

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(20)30254-3

pub_type

杂志文章,评审

相关文献

Brachytherapy文献大全
  • Improving patient-specific dosimetry for intravascular brachytherapy.

    abstract：PURPOSE:Accurate patient-specific dosimetry in intravascular brachytherapy (IVBT) is generally difficult due to the extremely high-dose gradient, complexity of treatment device, and patient-specific geometry (e.g., calcification, stent, curvature, movement of target). The purpose of this study is to analyze quantitativ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2005.07.004

    authors： Li XA,O'Neill M,Suntharalingam M

    更新日期：2005-01-01 00:00:00

  • Locally advanced cervical cancer in renal transplant patients: a dilemma between control and toxicity.

    abstract：PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...

    journal_title：Brachytherapy

    pub_type： 社论

    doi：10.1016/j.brachy.2013.11.003

    authors： Maroun P,Rivin E,Dumas I,Mondini M,Brahim J,Haie-Meder C,Mazeron R

    更新日期：2014-01-01 00:00:00

  • CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.

    abstract：PURPOSE:To evaluate the feasibility, efficacy, and safety of permanent (125)I seed interstitial brachytherapy reirradiation in patients with retroperitoneal lymph node recurrence under CT guidance. METHODS AND MATERIALS:Seventeen patients with 19 retroperitoneal lymph node recurrence after external beam radiotherapy u...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2015.05.008

    authors： Yao L,Jiang Y,Jiang P,Wang H,Meng N,Qu A,Tian S,Sun H,Liu C,Wang J,Zhang K

    更新日期：2015-09-01 00:00:00

  • A linear source table to determine the treatment times for cylindrical applicators used in high-dose rate brachytherapy.

    abstract：PURPOSE:It is a good practice for quality assurance purposes to check the high-dose rate brachytherapy source dwell times obtained from any computerized treatment planning system (TPS) by independent hand calculations. The aim of this work was to prepare a table that would help to calculate the total dwell times for cy...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2010.08.010

    authors： Sha RL,Reddy PY,Sahoo N

    更新日期：2011-05-01 00:00:00

  • Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.

    abstract：PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2012.05.003

    authors： Kotecha R,Yamada Y,Pei X,Kollmeier MA,Cox B,Cohen GN,Zaider M,Zelefsky MJ

    更新日期：2013-01-01 00:00:00

  • Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.

    abstract：PURPOSE:To compare clinical outcomes between low-dose-rate (LDR) brachytherapy and high-dose-rate (HDR) brachytherapy for cervical cancer patients. METHODS AND MATERIALS:All consecutive newly diagnosed cervical cancer patients undergoing pretreatment 18-fluorodeoxyglucose positron emission tomography imaging and treat...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2018.11.008

    authors： Lin AJ,Samson P,Zoberi J,Garcia-Ramirez J,Williamson JF,Markovina S,Schwarz J,Grigsby PW

    更新日期：2019-01-01 00:00:00

  • Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.

    abstract：PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes r...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(03)00134-X

    authors： Potters L,Calguaru E,Thornton KB,Jackson T,Huang D

    更新日期：2003-01-01 00:00:00

  • Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?

    abstract：PURPOSE:To choose the optimal brachytherapeutic modality for uterine cervical cancer, we performed simulation analysis. METHODS AND MATERIALS:For each high-risk clinical target volume (HR CTV), we compared four modalities [classical conventional intracavitary brachytherapy (ConvICBT), Image-guided ICBT (IGICBT), intra...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2015.10.002

    authors： Yoshida K,Yamazaki H,Kotsuma T,Takenaka T,Ueda MM,Miyake S,Tsujimoto Y,Masui K,Yoshioka Y,Sumida I,Uesugi Y,Shimbo T,Yoshikawa N,Yoshioka H,Tanaka E,Narumi Y

    更新日期：2016-01-01 00:00:00

  • Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors.

    abstract：PURPOSE:Determine whether fat distribution, body mass index, or clinical and dosimetric factors are associated with prostate specific antigen (PSA) bounce (PSAb) of ≥1.6 ng/mL in patients treated with permanent seed (125)I prostate brachytherapy (PB). METHODS AND MATERIALS:We identified 23 patients with a PSAb of ≥1.6...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2013.05.005

    authors： Chira C,Taussky D,Gruszczynski N,Meissner A,Larrivée S,Carrier JF,Donath D,Delouya G

    更新日期：2013-11-01 00:00:00

  • Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.

    abstract：PURPOSE:HDRILBT is one of the best methods of palliation for advanced esophageal cancer (AEC) by improving dysphagia-free survival (DFS) and overall survival (OS). This study examines if the addition of EBRT would further improve the outcome by improving DFS in AEC. METHODS AND MATERIALS:Patients with inoperable AEC w...

    journal_title：Brachytherapy

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/j.brachy.2004.09.004

    authors： Sur R,Donde B,Falkson C,Ahmed SN,Levin V,Nag S,Wong R,Jones G

    更新日期：2004-01-01 00:00:00

  • Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.

    abstract：PURPOSE:Describe the incidence and identify risk factors for seroma development after MammoSite breast brachytherapy (MBT). METHODS AND MATERIALS:MBT patient data were prospectively recorded into a quality assurance database. Departmental and electronic records were reviewed to extract patient-, treatment-, and outcom...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.07.001

    authors： Watkins JM,Harper JL,Dragun AE,Ashenafi MS,Sinha D,Li J,Cole DJ,Jenrette JM 3rd

    更新日期：2008-10-01 00:00:00

  • Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe.

    abstract：PURPOSE:Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and urinary toxicity of a minimal photovaporization (mPVP) before implantation. MATERIALS AND MET...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.08.003

    authors： Peigne C,Fournier G,Dissaux G,Delage F,Coquet JB,Boussion N,Goasduff G,Malhaire JP,Pradier O,Schick U,Valeri A

    更新日期：2021-01-01 00:00:00

  • Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy.

    abstract：PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.09.001

    authors： Boehle A,Katic K,König IR,Robrahn-Nitschke I,Brandenburg B

    更新日期：2020-01-01 00:00:00

  • A dosimetric comparison of three-dimensional conformal, intensity-modulated radiation therapy, and MammoSite partial-breast irradiation.

    abstract：PURPOSE:Limited information is available comparing target volume and normal tissue dosimetry with the different techniques of partial breast irradiation (PBI). We present results of a dosimetric comparison of single catheter, balloon-based brachytherapy using the MammoSite catheter (BRT), 3D conformal radiation therapy...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2006.06.001

    authors： Khan AJ,Kirk MC,Mehta PS,Seif NS,Griem KL,Bernard DA,Chu JC,Dickler A

    更新日期：2006-07-01 00:00:00

  • Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.

    abstract：PURPOSE:To explore the dosimetric advantage of target volume and surrounding normal tissue by using interstitial (IS) brachytherapy (BT) based on three-dimensional CT in locally advanced cervical cancer, as a simple and effective clinical treatment approach. METHODS AND MATERIALS:Fifty-two patients with poor tumor res...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.06.004

    authors： Liu ZS,Guo J,Lin X,Wang HY,Qiu L,Ren XJ,Li YF,Zhang BY,Wang TJ

    更新日期：2016-09-01 00:00:00

  • Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience.

    abstract：PURPOSE:With an aim to evaluate and report high dose date interstitial brachytherapy (HDR-ISBT) in vulvar cancers, we undertook this retrospective analysis. METHODS AND MATERIALS:Histologically proven vulvar cancers treated with HDR-ISBT between 2001 and 2016 were analyzed. Radiotherapy details, clinical outcome in te...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.10.003

    authors： Mahantshetty U,Naga P,Engineer R,Sastri S,Ghadi Y,Upreti U,Somesan V,Kadam S,Kohle S,Deshpande D,Shrivastava SK

    更新日期：2017-01-01 00:00:00

  • MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.

    abstract：PURPOSE:To establish dose-volume effect correlations for late small bowel (SB) toxicities in patients treated for locally advanced cervical cancer with concomitant chemoradiation followed by pulsed-dose rate MRI-guided adaptive brachytherapy. METHODS AND MATERIALS:Patients treated with curative intent and followed pro...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.04.004

    authors： Petit C,Dumas I,Chargari C,Martinetti F,Maroun P,Doyeux K,Tailleur A,Haie-Meder C,Mazeron R

    更新日期：2016-07-01 00:00:00

  • Clinical implementation of a novel Double-Balloon single-entry breast brachytherapy applicator.

    abstract：PURPOSE:The purpose of the study was to describe the clinical utilization of a novel Double-Balloon applicator for accelerated partial breast irradiation (APBI). METHODS AND MATERIALS:The Double-Balloon single-entry breast applicator contains a single central treatment catheter, as well as four peripheral catheters th...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.07.015

    authors： Anderson BM,Wallace CR,De Costa AA,Das RK

    更新日期：2017-01-01 00:00:00

  • Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation.

    abstract：PURPOSE:To assess the safety, feasibility, and efficacy of free-hand intraoperative multicatheter breast implant (FHIOMBI) and perioperative high-dose-rate brachytherapy (PHDRBT) in early breast cancer. METHODS AND MATERIALS:Patients with early breast cancer candidates for breast conservative surgery (BCS) were prospe...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2016.03.001

    authors： Cambeiro M,Martinez-Regueira F,Rodriguez-Spiteri N,Olartecoechea B,Insausti LP,Elizalde A,Gastearena MI,Gallego JS,Santisteban M,Aramendía JM,Aristu JJ,Moreno LA,Moreno-Jiménez M,Valtueña G,Martínez-Monge R

    更新日期：2016-07-01 00:00:00

  • Salvage low-dose-rate brachytherapy for local recurrences after prostatectomy and adjuvant or salvage external beam irradiation: Feasibility study on five patients and literature review.

    abstract：PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2020.07.001

    authors： Le Roy C,Gassa F,Rouvière O,Desmettre O,Bringeon G,Charret J,Serre AA,Pommier P

    更新日期：2021-01-01 00:00:00

  • A unique approach to high-dose-rate vaginal mold brachytherapy of gynecologic malignancies.

    abstract：PURPOSE:Patients with cervical and vaginal cancer sometimes have a less straightforward approach for choice of brachytherapy treatment owing to the tumor's location and clinical presentation. The staff at Royal Brisbane & Women's Hospital in Queensland, Australia, is trying to solve this problem by the use of an old te...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2014.10.004

    authors： Nilsson S,Moutrie Z,Cheuk R,Chan P,Lancaster C,Markwell T,Dawes J,Back P

    更新日期：2015-03-01 00:00:00

  • Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.

    abstract：PURPOSE:To analyze the dosimetric impact and periprocedural outcomes with a bioabsorbable hydrogel rectal spacer injected during low-dose-rate (LDR) prostate brachytherapy implants. METHODS AND MATERIALS:A consecutive series of 80 patients implanted with stranded I-125 LDR brachytherapy seeds were evaluated, of which ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.11.002

    authors： Kahn J,Dahman B,McLaughlin C,Kapoor P,Kapoor R,Harris E,Sharma M,Schutzer M,Moghanaki D

    更新日期：2020-01-01 00:00:00

  • Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity.

    abstract：PURPOSE:Accelerated partial breast irradiation (APBI) continues to increase in popularity. Up to 14% of patients treated with the MammoSite (MS) report some degree of chronic pain, which may be related to chest wall toxicity. Reports from several institutions using the multicatheter (MC) technique have not shown associ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2008.11.007

    authors： Cuttino LW,Todor D,Rosu M,Arthur DW

    更新日期：2009-04-01 00:00:00

  • LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.

    abstract：PURPOSE:Permanent LDR brachytherapy and temporary HDR brachytherapy are competitive techniques for clinically localized prostate radiotherapy. Although a randomized trial will likely never be conducted comparing these two forms of brachytherapy, a comparative radiobiological modeling analysis proves useful in understan...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/S1538-4721(02)00101-0

    authors： King CR

    更新日期：2002-01-01 00:00:00

  • A dose verification tool for high-dose-rate interstitial brachytherapy treatment planning in accelerated partial breast irradiation.

    abstract：PURPOSE:To develop a dose verification tool for high-dose-rate interstitial brachytherapy treatment planning in accelerated partial breast irradiation. METHODS AND MATERIALS:We have developed a software tool for interstitial brachytherapy treatment planning assessment. The software contains a database of seven (192)Ir...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2012.03.008

    authors： Marqa MF,Caudrelier JM,Betrouni N

    更新日期：2012-09-01 00:00:00

  • Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

    abstract：PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2009.01.002

    authors： Koontz BF,Chino J,Lee WR,Hahn CA,Buckley N,Huang S,Kim J,Reagan R,Joyner R,Anscher MS

    更新日期：2009-04-01 00:00:00

  • Evaluation of impact of an external breast shield (FlexiShield) in electronic brachytherapy for breast IORT: A phantom study.

    abstract：PURPOSE:To investigate Axxent (iCAD, Inc., San Jose, CA) electronic brachytherapy balloon deformation and its dosimetric impact because of an external flexible shield (FlexiShield [FS]; iCAD, Inc.). METHODS AND MATERIALS:Prostheses breast tissue phantom overlaid three spherical balloon applicators to simulate three cl...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2017.01.009

    authors： Kim Y,Huynh JW,Gonzalez VJ

    更新日期：2017-01-01 00:00:00

  • Quantitative estimation of doses to salivary glands from using brachytherapy in head and neck cancers.

    abstract：PURPOSE:To quantify the percentage doses received by salivary glands (SGDs) in head and neck interstitial brachytherapy (BT). METHODS AND MATERIALS:The study included 43 patients who underwent high-dose rate iridium-192 implant for oral cavity and oropharyngeal lesions treated with BT as a boost. BT dose varied with d...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2010.03.001

    authors： Bhalavat RL,Vyas S,Jamema SV,Upreti R,Talole S,Medhi S

    更新日期：2011-01-01 00:00:00

  • Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.

    abstract：PURPOSE:To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. METHODS:We included all 2,705 men treated with I-125 LDR brachytherapy monoth...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.10.005

    authors： Tom MC,Reddy CA,Smile TD,Zhang RX,Ciezki JP,Stephans KL,Mian OY,Klein EA,Campbell S,Ulchaker J,Angermeier K,Tendulkar RD

    更新日期：2020-01-01 00:00:00

  • Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.

    abstract：PURPOSE:The objective of this overview was to critically evaluate the effect of polyethylene glycol (PEG)-based hydrogel spacers during prostate brachytherapy with regard to dosimetric and clinical benefits, as well as procedure-related toxicity. METHODS AND MATERIALS:A systematic search in the PubMed database was per...

    journal_title：Brachytherapy

    pub_type： 杂志文章

    doi：10.1016/j.brachy.2019.08.009

    authors： Afkhami Ardekani M,Ghaffari H

    更新日期：2020-01-01 00:00:00